National Cancer Institute
Bethesda, USA · 16 authors
National Cancer Institute (Bethesda, USA): 16 authors and 2 papers in the de novo peptide sequencing catalog.
Papers (2)
- Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics (2023, Clinical Cancer Research)
- Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma (2021, Molecular & Cellular Proteomics)